Delcath Systems Announces up to $85 Million Financing

/PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and...

Related Keywords

United States ,Ben Shamsian ,Canaccord Genuity ,Prnewswire Delcath Systems Inc ,Company Seriesf Convertible Preferred Stock ,Company Or Delcath ,Nasdaq ,Drug Administration ,Serrado Capital ,Delcath Systems Inc ,Stonepine Capital Management ,Exchange Commission ,Vivo Capital ,Logos Capital ,Rosalind Advisors ,Seriesf Convertible Preferred Stock ,Securities Act ,Delcath Systems ,Hepatic Delivery System ,United States Food ,Delivery System ,Private Securities Litigation Reform Act ,Seriesf Preferred Stock ,Relations Contact ,Nc ,